An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil. Pediatr Emerg Care 1985 Dec;1(4):198-200
Date
12/01/1985Pubmed ID
3842166DOI
10.1097/00006565-198512000-00007Scopus ID
2-s2.0-0022328978 (requires institutional sign-in at Scopus site) 24 CitationsAbstract
A four-month-old infant with myocarditis and supraventricular tachycardia was given intravenous verapamil (0.1 mg/kg). Immediately following the dosage, the patient developed cardiovascular collapse. Aggressive, appropriate cardiopulmonary resuscitative efforts--including ventricular pacing--failed to reverse verapamil-induced decompensation. Myocarditis may have been responsible for our failure to resuscitate this infant successfully. To our knowledge, this is the first reported pediatric fatality following intravenous verapamil. We suggest that proven or suspected myocarditis should be added to the list of contraindications for intravenous verapamil therapy.
Author List
Garland JS, Berens RJ, Losek JD, Wilson ADAuthor
Richard J. Berens MD Professor in the Anesthesiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
HumansInfant
Male
Myocarditis
Shock
Tachycardia, Supraventricular
Verapamil
